The assessment of exposure in terms of fibres

Area of Science:

• Occupational health
• Environmental science
• Industrial hygiene

Background:

• Historical asbestos exposure studies relied on obsolete methods like the midget impinger (MI).
• Accurate assessment of long-term health risks necessitates converting these historical exposure indices to modern membrane filter (MF) equivalents.
• Reliability of conversion factors is critical for understanding asbestos-related disease risks.

Purpose of the Study:

• To review the reliability of converting historical asbestos exposure indices (e.g., MI) to membrane filter (MF) equivalent concentrations.
• To derive and apply conversion factors for specific worksites and industries.
• To investigate potential explanations for differing mesothelioma risks between mining areas and industries.

Main Methods:

• Reviewed reliability of converting obsolete exposure indices (MI, LRTP, TP) to MF concentrations.
• Derived site-specific conversion factors for Quebec mining and milling industry.
• Utilized side-by-side measurements to convert MI concentrations in the U.S. textile industry to MF concentrations.
• Analyzed lung tissue fiber concentrations and compared chrysotile to tremolite ratios.

Main Results:

• No single overall conversion factor for the Quebec mining industry; site-specific factors were derived.
• An overall MF/MI ratio of 3.6 was calculated for a Quebec mortality study.
• Conversions for the U.S. textile industry show consistency in lung tissue fiber ratios (chrysotile to tremolite) with assessed exposures.
• Lung cancer dose-response is significantly higher in the textile industry compared to mining/milling.
• Higher mesothelioma risk in Thetford Mines linked to high tremolite concentration.

Conclusions:

• Site-specific conversion factors are essential for accurate asbestos exposure assessment.
• Tremolite exposure may contribute to mesothelioma risk in chrysotile mining.
• Differences in fiber size distribution between industries warrant further investigation for lung cancer risk assessment.